Skip to content
DataLookout
Menu

Changes this week

Changes detected in the 7 days to Nov 20, 2026

  1. Minor: RO7965032 · Geographic Atrophy Secondary to Age-Related Macular Degeneration Trial sites expanded: 5 → 9 locations Genentech, Inc.Phase 2 NCT07851259
  2. Minor: Mirivadelgat in PH-ILD (Windward) Trial sites expanded: 11 → 15 locations Foresee Pharmaceuticals Co., Ltd.Phase 2 NCT06475781
  3. Minor: VTX2735 in Recurrent Pericarditis Trial sites expanded: 19 → 28 locations Zomagen Biosciences Ltd.Phase 2 NCT06836232
  4. Minor: Symbiotic-GU-06 · PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer Trial sites expanded: 184 → 198 locations PfizerPhase 1/2 NCT07421700
  5. Minor: Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC Trial sites expanded: 37 → 66 locations PfizerPhase 2 NCT07489066
  6. Minor: Aztreonam-Avibactam (ATM-AVI) in Infants and Newborns Admitted in Hospitals With Bacterial Infection (CHERISH) Trial sites expanded: 30 → 36 locations PfizerPhase 2 NCT06462235
  7. Minor: [212Pb]Pb-DOTAM-MAM279 ([212Pb]Pb-MP0712) · Small Cell Lung Cancer and Other DLL3 Expressing Solid Tumors Trial sites expanded: 6 → 9 locations Molecular Partners AGPhase 1/2 NCT07278479
  8. Minor: Symbiotic-GI-13 · PF-08634404 as a Single Treatment and Combination Treatment · a Liver Cancer Called Hepatocellular Carcinoma, That is Too Advanced to be Removed by Surgery and May Have Spread to Other Parts of the Body Trial sites expanded: 58 → 81 locations PfizerPhase 1/2 NCT07227012
  9. Minor: Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers Trial sites expanded: 104 → 108 locations PfizerPhase 1/2 NCT07227298
  10. Minor: MAR001 · Elevated Triglycerides and Remnant Cholesterol Trial sites expanded: 55 → 62 locations Marea TherapeuticsPhase 2 NCT07028749
  11. Minor: Taking an Additional Dose of the Medicine Rimegepant · Migraine Trial sites expanded: 24 → 38 locations PfizerPhase 4 NCT07609914
  12. Minor: Symbiotic-Lung-14: A Study to Learn About the Study Medicine Called PF08634404 in Combination With Chemotherapy · Transformed Small Cell Lung Cancer Trial sites expanded: 61 → 75 locations PfizerPhase 2 NCT07476287
  13. Minor: Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions and Subcutaneous Injections of ABBV-519 · Systemic Lupus Erythematosus (SLE) or Rheumatoid Arthritis (RA) Trial sites expanded: 13 → 17 locations AbbViePhase 1 NCT07607964
  14. Minor: AIR-001 · Alpha-1 Antitrypsin Deficiency (AATD) Trial sites expanded: 12 → 15 locations AIRNA CorporationPhase 1 NCT07431112
  15. Minor: UmbREALung - A Retrospective and Prospective, Observational, Real World Multi-cohort Study · Non-small Cell Lung Cancer (NSCLC) Initiating Approved Drugs Developed by AZ or as Part of an AZ Alliance Trial sites expanded: 52 → 85 locations AstraZenecaNot specified NCT06726720
  16. Minor: OPTION-EMEA Clinical Trial Trial sites expanded: 11 → 14 locations Boston Scientific CorporationNot applicable NCT07349121
  17. Minor: Global Paradise System US Post Approval Study Trial sites expanded: 46 → 49 locations ReCor Medical, Inc.Not specified NCT06297291
  18. Minor: Voice-based Outcome Identification and Clinical Evaluation in Heart Failure Trial sites expanded: 0 → 4 locations Noah LabsNot specified NCT07870395
  19. Minor: BIO|MASTER.CorSky Family Post-market Study for the CorSky Family of ICDs Trial sites expanded: 7 → 15 locations Biotronik SE & Co. KGNot specified NCT07360158
  20. Minor: Elite AF IDE Trial (Elite AF) Trial sites expanded: 0 → 5 locations Boston Scientific CorporationNot applicable NCT07287436
  21. Minor: EVERO Drug-coated Balloon (DCB) Randomized Trial Trial sites expanded: 15 → 19 locations Cook Research IncorporatedNot applicable NCT07144150
  22. Minor: Immunotherapy After Surgery · No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial Trial sites expanded: 284 → 287 locations National Cancer Institute (NCI)Phase 3 NCT06498635
  23. Minor: Knee Cartilage Repair Registry Trial sites expanded: 6 → 9 locations Smith & Nephew, Inc.Not specified NCT07786207
  24. Minor: Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial Trial sites expanded: 148 → 171 locations National Cancer Institute (NCI)Phase 3 NCT07388524
  25. Minor: Different Treatment Lengths for Venetoclax · Newly Diagnosed Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial) Trial sites expanded: 69 → 83 locations National Cancer Institute (NCI)Phase 2 NCT07437950